Navigation Links
Xceed Ziplex(R) System for Automated Gene-Expression Analysis Wins 2008 R&D 100 Award
Date:8/19/2008

WELLESLEY, Mass., Aug. 19 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced that R&D Magazine has selected the company's Ziplex System as a recipient of the magazine's prestigious R&D 100 Award. Called the Oscars of Invention by The Chicago Tribune, the 45-year-old R&D 100 Award, is according to R&D, "a mark of excellence known to industry, government, and academia as proof that the product is one of the most innovative ideas of the year." Xceed's Ziplex System - comprising an automated hybridization workstation, Autograph and Xpress Chip(TM) consumable arrays, reagents, and automated analysis/reporting software - is the first integrated system for automated gene-expression analysis.

"We are honored to become a member of this elite group of R&D 100 award winners, whose inventions have contributed so much to society," said Xceed President and CEO, David Deems. "This award is a wonderful testament to the talented team of designers, hardware and software engineers, microarray and biochemistry experts who have worked tirelessly over the years to take a complex, expensive, and time-consuming process - gene-expression analysis - and turn it into a simple, reproducible, and affordable one, where results remain consistent even when samples are run by different people, at different times, or in different sites."

As translational medicine moves from the research laboratory to the clinical laboratory, technology that is affordable, reliable, and easy to operate will be critical. The translational process refines a gene-expression signature from hundreds of genes identified in the research stage to the 10 to 150 genes that comprise the final diagnostic assay. Increasingly, investigators are concerned that experiments conducted at different points in time, at multiple locations, or by multiple users may not be comparable due to inherent variability in analytical technology platforms and methodologies. In addition, with the growing amount of data generated from these studies, investigators need guidance and assistance in ensuring quality control in data collection, sample integrity, and analysis.

Designed to make routine molecular diagnostics easy, reproducible, and affordable to serve the rigorous performance and quality-control needs of both clinical research and clinical-diagnostic settings, the Ziplex System is rapidly becoming the system of choice for the nation's leading institutions performing translational research. The system incorporates turnkey functionality and significant advances in automation, array format, fluidics, parallel sample processing, and analytics to minimize complexity, user interaction, and variability between users and sites.

About Xceed Molecular (http://www.XceedMolecular.com)

Xceed's vision is to advance molecular diagnostics by successfully translating novel multiplex tests into routine clinical practice and to create robust diagnostic solutions to improve disease outcomes. Our products comprise the Ziplex System for automated gene-expression analysis (available in the US and Canada for research use only), gene expression services, customized arrays - Autograph Chips, and pre-configured arrays - Xpress Chips. Xceed is also developing multiplexed genomic tests for the Ziplex platform, both internally and with strategic partners. Xceed's R&D and manufacturing are headquartered in Toronto, Ontario, with executive offices in Wellesley, Massachusetts.


'/>"/>
SOURCE Xceed Molecular
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008
2. Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155
3. Xceed Molecular Grants Gen-Probe License to Xceeds Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics
4. Xceed Molecular Features Ziplex(R) Automated Gene-Expression System at the Biomarker World Congress, Booth 16
5. Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million
6. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
7. Cephalons 2007 Results Exceed Full Year Sales and Earnings Guidance
8. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
9. Center for Molecular Medicine Offers Xceed Ziplex(TM) Services to Research Community
10. CNCA Exceeds Standards in Nutritional Supplement Quality, Protects Public
11. CrossFire Beilstein Database Exceeds Ten Million Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... development of precision treatments for neurodegenerative diseases, today announced it has issued a ... approach.” This is one of a series of commentaries from ProMIS’s scientific team ...
(Date:2/22/2017)... , Feb 22, 2017 Dublin ... the "Global Biological Crop Protection (Bio-Pesticide) Market-By Type, By Application, ... report to their offering. ... Global Biological Crop Protection Market is forecasted to ... The strong growth in biopesticide or biological crop protection market is ...
(Date:2/22/2017)... ... February 22, 2017 , ... NDA Partners ... MD former Acting Deputy Director in the FDA CDRH Division of Cardiovascular, Respiratory, ... joined the company as an Expert Consultant. , In Dr. Spyker’s accomplished career, ...
(Date:2/22/2017)... N.C., Feb. 22, 2017  United Therapeutics Corporation (NASDAQ: ... results for the fourth quarter and year ended ... results reflect continued growth as net revenues reached ... Martine Rothblatt, Ph.D., United Therapeutics, Chairman and Chief ... to develop and advance our growing product pipeline, ...
Breaking Biology Technology:
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):